Jesse L. Goodman, MD, MPH is Professor of Medicine and Infectious Diseases and Attending Physician at Georgetown University. He was previously Chief of Infectious Diseases at the University of Minnesota where his laboratory isolated the causative agent of human granulocytic anaplasmosis. From 2003-9 he served as Director of the Center for Biologics Evaluation and Research (CBER), regulating vaccines, blood and cell and gene therapies, and then as Chief Scientist of the US FDA until 2014, serving in US leadership for numerous public health responses. He is a member of the National Academy of Medicine and has served on numerous WHO, CDC, NIH, NAM and other advisory committees and previously served as a member of GSK’s board, chairing its science committee.